The prevalence of peripheral vascular disease in familial hypercholesterolaemia

Abstract. Objectives. In patients with familial hypercholesterolaemia (FH), the prevalence of haemodynamically significant peripheral vascular disease (PVD) was measured in relation to lipoproteins, general risk factors and the presence of coronary artery disease (CAD).

[1]  S. Nilsson,et al.  The relation of coronary and peripheral arterial disease to the severity of femoral atherosclerosis in hypercholesterolaemia , 1994, Journal of internal medicine.

[2]  O. Wiklund,et al.  Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[3]  J. Polak,et al.  Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. , 1993, Circulation.

[4]  O. Wiklund,et al.  Arterial wall thickness in familial hypercholesterolemia. Ultrasound measurement of intima-media thickness in the common carotid artery. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  P. Demacker,et al.  N‐acetylcysteine and serum concentrations of lipoprotein(a) , 1991, Journal of internal medicine.

[6]  W N van Asten,et al.  Assessment of aortoiliac obstructive disease by Doppler spectrum analysis of blood flow velocities in the common femoral artery at rest and during reactive hyperemia. , 1991, Surgery.

[7]  M. Hayden,et al.  Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[8]  H. V. van Lier,et al.  Effect of distal occlusions on the assessment of aorto-iliac pathology by analysis of Doppler spectra. , 1991, Ultrasound in medicine & biology.

[9]  D. Steinberg,et al.  Role of oxidised low density lipoprotein in atherogenesis. , 1993, British heart journal.

[10]  E. Boerwinkle,et al.  Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. , 1990, The New England journal of medicine.

[11]  L. Carbone,et al.  Different localization of early arterial lesions in insulin-dependent diabetes mellitus and in familial hypercholesterolemia. , 1989, Metabolism: clinical and experimental.

[12]  I. Makino,et al.  Increased frequencies of apolipoprotein ε2 and ε4 alleles in patients with ischemic heart disease , 1989 .

[13]  K. Salmenkivi,et al.  Peripheral atherosclerosis in familial hypercholesterolaemia , 1989, Journal of internal medicine.

[14]  A. Olsson,et al.  Prevalence of femoral atherosclerosis in asymptomatic men with hyperlipoproteinaemia , 1989, Journal of internal medicine.

[15]  T. Funahashi,et al.  Clinical features of familial hypercholesterolemia. , 1989, Arteriosclerosis.

[16]  M. Thorogood,et al.  Genotypic and phenotypic variation in familial hypercholesterolemia. , 1989, Arteriosclerosis.

[17]  P. Koivisto,et al.  Peripheral arterial disease in heterozygous familial hypercholesterolemia: no difference between patients with and without partial ileal bypass. , 1988, Atherosclerosis.

[18]  T. Farag,et al.  Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.

[19]  L. Chambless,et al.  The association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease. The Lipid Research Clinics Program Prevalence Study. , 1986, Circulation.

[20]  A. DeMaria,et al.  Comparative accuracy of two-dimensional echocardiography and Doppler pressure half-time methods in assessing severity of mitral stenosis in patients with and without prior commissurotomy. , 1986, Circulation.

[21]  U. Francke,et al.  Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase with cDNA probes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Mancini,et al.  Premature Development of Iliac Artery Stenosis in Asymptomatic Type II Hyperlipoproteinemia , 1984, Arteriosclerosis.

[23]  M. Lepäntalo,et al.  The ankle/arm systolic blood pressure ratio as a screening test for arterial insufficiency in the lower limb. , 1983, Annales chirurgiae et gynaecologiae.

[24]  P. Demacker,et al.  A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. , 1980, Clinical chemistry.

[25]  E. Bernstein,et al.  The importance of combined multisegmental pressure and Doppler flow velocity studies in the diagnosis of peripheral arterial occlusive disease. , 1978, Surgery.

[26]  H. Mabuchi,et al.  Homozygous familial hypercholesterolemia in Japan. , 1978, The American journal of medicine.

[27]  J. Beaumont,et al.  Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases. , 1976, Atherosclerosis.

[28]  E. Bernstein,et al.  Quantitative Ultrasonographic Studies of Lower Extremity Flow Velocities in Health and Disease , 1976, Circulation.

[29]  A. Heiberg.  The risk of atherosclerotic vascular disease in subjects with xanthomatosis. , 2009, Acta medica Scandinavica.

[30]  J. Verter,et al.  Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia , 1974, Circulation.

[31]  G. Ehrlich,et al.  The Metabolic Basis Of Inherited Disease. , 1973 .

[32]  T. Miettinen,et al.  Comparison of clinical findings in patients with hyperglyceridaemia and familial hypercholesterolaemia. , 1973, Annals of clinical research.

[33]  W. Kannel,et al.  Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study. , 1972, JAMA.

[34]  H. Uchino,et al.  DEPARTMENT OF INTERNAL MEDICINE , 1966 .